The U.S. shortfall is overshadowing the stronger-than-expected results in Europe and APMEA.


For the second consecutive month, MCD’s same-store sales results fell short of street expectations in the U.S. while exceeding consensus estimates in Europe and APMEA.  The company’s comps came in up 2.7% in the U.S. relative to the street’s 3.6% estimate, up 5.1% in Europe versus the street at +3.6% and up 4.0% in APMEA, much better than the street’s +1.8% estimate.


Trends in Europe have remained solid for the second consecutive month after decelerating sharply in December.  Although two-year average trends decelerated nearly 70 bps in February on a calendar-adjusted basis, this was expected after the more than 400 bp sequential improvement in January. 


MCD’s APMEA segment posted its third consecutive month of accelerating two-year average trends in February.  The company’s +4.0% comp growth was particularly impressive given the fact it was lapping a+10.5% comp from February 2010.


Despite these strong results internationally, MCD overall results are being overshadowed today by the lower-than-expected U.S. numbers.  Although MCD is a global company, MCD’s U.S. segment still accounts for about 45% of the company’s total operating income and investor sentiment still seems to be driven largely by the U.S. story.


Two-year average trends in the U.S. moved slightly higher in February, up nearly 20 bps to about 1.7% (on a calendar-adjusted basis).  Although some investors may be encouraged by this sequential improvement, I continue to think people are too bullish about MCD’s momentum in the U.S. as evidenced by the company’s posting another monthly comp result below expectations.


I continue to believe MCD’s comp trends will slow as we progress through the year and the reported March same-store sales result will likely turn negative as the company faces its first difficult monthly comparison of the year.  In March 2010, MCD reported a +4.2% comp relative to -0.7% in January and +0.6% in February of 2010.  Even if the company can maintain its two-year average trend from February, it would imply a -1.6% comp in March.  For reference, MCD has not posted a decline in monthly same-store sales growth since January 2010.


The comparisons will remain difficult for the balance of the year, particularly in the summer months when the company laps its initial smoothie/frappe rollout.  MCD has said that 2-3% comp growth is necessary in the U.S. to maintain margins in 2011 as a result of commodity inflation.  If the company can maintain two-year average trends for the remainder of the year, it implies a 0.5% decline in FY11 same-store sales growth in the U.S. and I would not be surprised to see two-year average trends decelerate from current levels.  Either way, I would expect MCD’s U.S. comp results to fall short of investor expectations in FY11.








Howard Penney

Managing Director



Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more

McCullough: ‘My 1-Minute Summary of My Institutional Meetings in NYC Yesterday’

What are even some of the smartest investors in the world missing right now?

read more

Cartoon of the Day: Political Portfolio Positioning

Leave your politics out of your portfolio.

read more

Jim Rickards Answers the Hedgeye 21

Bestselling author Jim Rickards says if he could be any animal he’d be a T-Rex. He also loves bonds and hates equities. Check out all of his answers to the Hedgeye 21.

read more

Amazon's New 'Big Idea': Ignore It At Your Own Peril

"We all see another ‘big idea’ out of Amazon (or the press making one up) just about every day," writes Retail Sector Head Brian McGough. "But whatever you do, DON’T ignore this one!"

read more